NCT04050761View on ClinicalTrials.gov

A Study of Nivolumab in Patients With Head and Neck Cancer.

CompletedOBSERVATIONAL
Enrollment

502

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

July 8, 2024

Study Completion Date

July 8, 2024

Conditions
Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck
Interventions
BIOLOGICAL

Nivolumab

Specified dose on Specific Days

Trial Locations (1)

75005

Local Institution - 0001, Paris

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY